Influenza virus vaccine (Sinovac Biotech)

流感病毒裂解疫苗（科兴生物）

Report date: 2026/05/20 20:02:01

Base Information

Drug NameInfluenza virus vaccine (Sinovac Biotech)
Drug Alias Name三价流感病毒裂解疫苗（科兴生物）Split influenza virus vaccine - Sinovac BiotechInfluenza Vaccine (Split Virion), Inactivated - Sinovac BiotechAnflu安尔来福
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2005/07/22
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinovac Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Ltd
Inactive CompaniesSinovac Biotech Co Ltd
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksN/A